Incyte
INCY
$57.05
Share price
0.00%
Change (1 day)
-13.82%
Change (1 year)
Categories
Incyte (INCY) - Total debt
Total debt on the balance sheet as of March 2024 : $37.39 M
According to Incyte's latest financial reports the company's total debt is $37.39 M. A company’s total debt is the sum of all current and non-current debts.
Incyte - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $38.28 M | -7.65% |
| 2022-12-31 | $41.45 M | -7.51% |
| 2021-12-31 | $44.82 M | -5.7% |
| 2020-12-31 | $47.53 M | -21.08% |
| 2019-12-31 | $60.22 M | 66.69% |
| 2018-12-31 | $36.13 M | 50.54% |
| 2017-12-31 | $24 M | -96.32% |
| 2016-12-31 | $0.65 B | 5.1% |
| 2015-12-31 | $0.61 B | -8.19% |
| 2014-12-31 | $0.67 B | 2.06% |
| 2013-12-31 | $0.66 B | 99.82% |
| 2012-12-31 | $0.33 B | 4.72% |
| 2011-12-31 | $0.31 B | 7.74% |
| 2010-12-31 | $0.29 B | -33.78% |
| 2009-12-31 | $0.44 B | 11.86% |
| 2008-12-31 | $0.39 B | 2.49% |
| 2007-12-31 | $0.38 B | 4.16% |
| 2006-12-31 | $0.37 B | 8.55% |
| 2005-12-31 | $0.34 B | -9.74% |
| 2004-12-31 | $0.37 B | 125.74% |
| 2003-12-31 | $0.16 B | -2.47% |
| 2002-12-31 | $0.17 B | -4.02% |
| 2001-12-31 | $0.17 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $27.28 B | 72,861.63% | 🇨🇭 Switzerland |
 Pfizer PFE | $70.84 B | 189,350.46% | 🇺🇸 USA |
 Eli Lilly LLY | $26.21 B | 69,993.33% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 172,685.13% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $6.16 M | -83.51% | 🇺🇸 USA |
 Geron GERN | $85.89 M | 129.71% | 🇺🇸 USA |
 CTI BioPharma
CTIC | $48.89 M | 30.75% | 🇺🇸 USA |
 AVEO Oncology
AVEO | $38.68 M | 3.44% | 🇺🇸 USA |
 Ardelyx ARDX | $55.98 M | 49.70% | 🇺🇸 USA |